Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: The Alpine republic with a population of 8.8 million has tested around 28,400 people so far with nearly 4,900 cases and 28 deaths confirmed. It was one of the first European countries to put severe restrictions on movement and close shops and schools in response to the developments in neighboring Italy and a strong increase in coronavirus infections in its western regions. In coming weeks, Austria plans to test up to 15,000 people per day, the chancellor said. “We will also launch rapid tests, to test hundreds of thousands of people, as quickly as possible,” Kurz told a news conference. He referred to brand new tests that are comparably cheap but take longer than laboratory tests used up until now. Broad testing is key to getting a clear picture of the real infection rate and an idea of how many people have developed immunity against the virus, the chancellor said. Top priority was to delay the peak of infections as long as possible to avoid a situation like in Italy or Spain, where the health systems are overwhelmed. “Our goal is that the number of infections doubles only every 14 days and not every two, three or five days and that we will set the right measures to keep it that way once we ramp up social life again,” Kurz said. Austria’s strict measures are in place until April 13, and Kurz said there was hope that a gradual withdrawal could start the day after. A government task force developing scenarios for the “ramp up” was currently dealing with questions such as in which order schools, businesses and production should restart. Lessons from other countries showed that it was crucial to remain disciplined and to make use of “big data”. Asked what he meant by “big data”, Kurz said: “We are currently working with the Red Cross and other enterprises on ideas that could be implemented in Austria and in Europe, and which are suitable for our system and our democracy.”   Austria’s Red Cross is promoting a so-called “Stop Corona” app, which enables a user to digitally store who he meets and when. If a person shows symptoms of corona disease, these contact persons can be notified. Austria’s mobile carrier A1 Telekom Austria  is already sharing results from a motion analysis application that visualizes the movement flows of groups of people with the health authority. Claim: Austria bets on mass testing to manage coronavirus spread.

A: Austria will massively expand coronavirus testing in coming days to locate and isolate infected people and avoid an Italian-like overload of its health system, Chancellor Sebastian Kurz said on Tuesday.
****
Q: Paragraph: The Food and Drug Administration approved Medtronic’s CoreValve system based on U.S. clinical trials in which it was shown to be safe and effective while demonstrating low rates of stroke and valve leakage, the company said. CoreValve, in which the replacement valve is threaded into place through an artery using a catheter, spares patients chest-cracking surgery. The system has been available since 2007 in Europe, where it is not uncommon for medical devices to win approval several years ahead of the United States. Claim: U.S. FDA approves Medtronic heart valve replacement system.

A: Medtronic Inc’s non-invasive systems for replacing diseased heart valves won U.S. approval for use in patients deemed too frail to endure traditional open heart surgery, the U.S. medical device maker said on Friday.
****
Q: Paragraph: The device, known as a renal denervation system, belongs to a class of products that take a new approach to treating hypertension and are aimed at patients resistant to traditional drug-based therapies. Covidien’s device is approved in Europe and is being tested in the United States. The adoption of such devices has been slow as austere governments are reluctant to pay for the unconventional technology. These devices work by creating tiny scars along nerves in the kidneys - organs that play a pivotal role in regulating blood pressure by sending signals to the brain that can cause blood vessels to constrict. This scarring process is carried out by threading a catheter through the renal arteries from the groin. It deadens the nerves and decreases blood pressure. Covidien said the decision to exit the business was a result of its regular review of strategic programs. Covidien said it expects to record after-tax charges of $20-$25 million as a result of exiting the program. The company’s shares were unchanged in light premarket trading on Tuesday. Claim: Covidien to stop making hypertension devices.

A:
Covidien Plc said it would stop making devices for treating high blood pressure due to weak industry-wide demand.
****